This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Learn about the efficacy and safety of Somavert, its tumour impact and its effect on co-morbidity management through clinical and real world data

The acromegaly disease activity tool designed to help monitor your patients

Advice and support services to help you and your patients optimise your experience with Somavert about the efficacy and safety of Somavert through clinical and real world data

Learn about funding and reimbursement England, Scotland, Wales and Northern Ireland

Watch and listen to acromegaly experts talk about various topics in the disease area as well as recordings from our National Nurse Meeting and the Acromegaly co-morbidity series

Click here for Somavert® (pegvisomant) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Somavert is used in the treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalise IGF-I concentrations or was not tolerated.

The Endocrine Helpline

Patients receiving homecare services will have their own dedicated, nurse-led helpline to support with patient enquiries

All patients with either standard or the enhanced AcroCare homecare services will be given their own dedicated helpline number to call

Endocrine helpline

A freephone Pfizer Endocrine Helpline service is also available to clinicians and patients on 0800 521249
Email: [email protected]
Opening hours
Monday - Thursday: 9am - 5pm
Friday only: 9am - 4pm
(Answer phone available out of hours)

The Pfizer Endocrine Helpline team of nurses provides direct support for patients not receiving homecare services

We typically handle any queries relating to medication and supplies deliveries, reconstitution and self-administration advice.

Homecare services

We offer a range of services that help your patients at home with medication delivery and face-to-face support

Learn more

Order more starter kits

Order now

PP-SOM-GBR-0954. June 2021

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No